PubMed · 5304148
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
L Ribeiro. 1968. [Clinical dactyloscopy].. https://pubmed.ncbi.nlm.nih.gov/5304148/
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
The reaction products of 1,2-indanedione (a new fluorescent fingerprint reagent) with glycine in methanol, at room temperature have been studied using excitation and emission and time-resolved fluorescence spectroscopy. Gas chromatography-mass spectroscopy (GC/MS) has also been used to determine which compounds are formed. Reaction products were identified using GC/MS as 2-carboxymethyliminoindanone (MW=203 g) and 1,2-di(carboxymethylimino)indane (MW=260 g). Identified compounds show room temperature fluorescence lifetimes of tau(1)=7.69 ns and tau(2)=1.27 ns. It is not clear yet which compound is having fluorescence lifetime of 7.69 ns and which one is showing 1.27 ns.
Dermatoglyphic anomalies are reported to occur at a higher rate in schizophrenic patients and schizotypic individuals than in the general population, supporting the hypothesis that they are a marker of vulnerability for such conditions. Dermatoglyphic anomalies are hypothesized to indicate severe disruptions in the second trimester of prenatal development, a time period that appears to be etiologically relevant to the development of schizophrenia and related conditions. The present study provides the first examination of extralimital triradii in schizotypic young adults (n=197) and control participants (n=135) identified by the Revised Social Anhedonia Scale [Eckblad, M., Chapman, L.J., Chapman, J.P., Mishlove, M., 1982. The Revised Social Anhedonia Scale. Unpublished test (copies available from T.R. Kwapil, Department of Psychology, University of North Carolina at Greensboro P.O. Box 26164 Greensboro, NC 27402-6164)], the Perceptual Aberration Scale [Chapman, L.J., Chapman, J.P., Raulin, M.L., 1978. Body image aberration in schizophrenia. J. Abnorm. Psychol. 87, 399--407], the Magical Ideation Scale [Eckblad, M.L., Chapman, L.J., 1983. Magical ideation as an indicator of schizotypy. J. Consult. Clin. Psychol. 51, 215--225], and the Physical Anhedonia Scale [Chapman, L.J., Chapman, J.P., Raulin, M.L., 1976. Scales for physical and social anhedonia. J. Abnorm. Psychol. 85, 374--382]. As hypothesized, the schizotypic participants (6.6%) exhibited significantly higher rates of extralimital triradii than control participants (1.5%). These findings strongly encourage the future investigation of extralimital triradii in at-risk and psychotic populations.
BACKGROUND: Patients with schizophrenia show deviances in their dermatoglyphics, in particular reductions in palmar a-b ridge counts (ABRCs), which are evidence of an early developmental deviance. However, the severity or the origin of these ABRC changes has not been established. METHOD: (i) We examined the published literature on the ABRC in patients with schizophrenia against controls with a random effects meta-analysis. (ii) We used linear regression to study the ABRC in our sample of families including 125 patients with schizophrenia, 107 of their unaffected relatives and 98 controls. (iii) The effect of obstetric complications on the patient's ABRC was examined using the Lewis Murray scale. RESULTS: The pooled standardised effect size of ABRC differences between patients and controls obtained by our meta-analysis was 0.39 (95% CI: 0.05-0.73; p=0.03). In our sample, there were no significant differences in ABRCs between those with schizophrenia, their relatives and controls. Only those patients with obstetric complications had significantly reduced ABRC compared to controls (p=0.01). CONCLUSIONS: We confirmed the presence of significant yet mild ABRC reductions in schizophrenia. These represent a subtle deviance from the norm and could be present in certain subsets of patients, possibly those who suffered early developmental insults.